AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18836152 — intervention group
Group type: COMPARATOR
Intervention: Undiagnosed diabetes (fasting blood glucose >or=7.0 mmol/L without diagnosed diabetes; n = 55)
Number of subjects: 1917
Study 18836152 — intervention group
Group type: COMPARATOR
Intervention: Impaired fasting glucose (fasting blood glucose 5.6-6.9 mmol/L; n = 744)
Number of subjects: 1917
Study 18836152 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemics (control group)
Number of subjects: 1917
Study 16219312 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 500
Study 16219312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 12791104 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ)
Number of subjects: 0
Study 12791104 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxamniquine (OXAM)
Number of subjects: 0
Study 12791104 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated children)
Number of subjects: 0
Study 11026393 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive outcomes occurring randomly on 33% of trials
Number of subjects: 0
Study 11026393 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive outcomes occurring randomly on 66% of trials
Number of subjects: 0
Study 11026393 — intervention group
Group type: EXPERIMENTAL
Intervention: Varying number of response alternatives (two, three, or six)
Number of subjects: 0
Study 11026393 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' scores on Burger and Cooper's 1979 Desirability of Control scale
Number of subjects: 0
Study 8632540 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative M-VAC chemotherapy (2 courses before surgery and 3 courses after surgery)
Number of subjects: 100
Study 8632540 — intervention group
Group type: COMPARATOR
Intervention: Postoperative M-VAC chemotherapy (5 adjuvant courses following cystectomy)
Number of subjects: 100
Study 8632540 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative M-VAC chemotherapy
Number of subjects: 100
Study 8632540 — intervention group
Group type: COMPARATOR
Intervention: Postoperative M-VAC chemotherapy
Number of subjects: 100
Study 8632540 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 1945214 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 60
Study 1945214 — intervention group
Group type: COMPARATOR
Intervention: Nylidrin
Number of subjects: 60
Study 1945214 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 6841934 — intervention group
Group type: EXPERIMENTAL
Intervention: Job club program
Number of subjects: 46
Study 6841934 — intervention group
Group type: COMPARATOR
Intervention: Normally available services (control)
Number of subjects: 46
Study 30856210 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening mammography
Number of subjects: 25318
Study 30856210 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with higher false-positive recall
Number of subjects: 25318
Study 30856210 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with lower risk of false-positive recall
Number of subjects: 25318
Study 30856210 — intervention group
Group type: EXPERIMENTAL
Intervention: Further adjustment of percent mammographic density
Number of subjects: 25318
Study 30095232 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention (PEERS® intervention)
Number of subjects: 41
Study 30095232 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention group (control)
Number of subjects: 41
Study 26946729 — intervention group
Group type: EXPERIMENTAL
Intervention: menstrual cycle-based acupuncture therapy
Number of subjects: 63
Study 26946729 — intervention group
Group type: COMPARATOR
Intervention: IVF-ET (control group)
Number of subjects: 63
Study 23235718 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet
Number of subjects: 20
Study 23235718 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetic diet
Number of subjects: 20
Study 22293584 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin + EPA (1,800 mg/day for 6 months)
Number of subjects: 28
Study 22293584 — intervention group
Group type: COMPARATOR
Intervention: Statin alone
Number of subjects: 28
Study 19927132 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring
Number of subjects: 636
Study 19927132 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 636
Study 19927132 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 636
Study 19927132 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 636
Study 17353443 — intervention group
Group type: COMPARATOR
Intervention: Fixed lower-energy regimen (150-150-150 J)
Number of subjects: 221
Study 17353443 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalating higher-energy regimen (200-300-360 J)
Number of subjects: 221
Study 17353443 — intervention group
Group type: COMPARATOR
Intervention: First shock success (Fixed lower)
Number of subjects: 221
Study 17353443 — intervention group
Group type: EXPERIMENTAL
Intervention: First shock success (Escalating higher)
Number of subjects: 221
Study 16127249 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body MRI (WB‐MRI)
Number of subjects: 16
Study 16127249 — intervention group
Group type: COMPARATOR
Intervention: Bone scintigram (BS)
Number of subjects: 16
Study 12401596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine/neostigmine mixture (0.25% bupivacaine 1 mL/kg + neostigmine 2 micro g/kg)
Number of subjects: 60
Study 12401596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine (0.25% bupivacaine 1 mL/kg)
Number of subjects: 60
Study 12401596 — intervention group
Group type: COMPARATOR
Intervention: Caudal neostigmine (2 micro g/kg in normal saline 1 mL/kg)
Number of subjects: 60
Study 12401596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine/neostigmine mixture
Number of subjects: 60
Study 12401596 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine
Number of subjects: 60
Study 12401596 — intervention group
Group type: COMPARATOR
Intervention: Caudal neostigmine
Number of subjects: 60
Study 10452884 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular Stapled Anastomosis (CSA)
Number of subjects: 0
Study 10452884 — intervention group
Group type: COMPARATOR
Intervention: Double Stapling Anastomosis (DSA)
Number of subjects: 0
Study 8560532 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (35 mg/kg over 3 days)
Number of subjects: 123
Study 8560532 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg over 3 days)
Number of subjects: 123
Study 8560532 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 123
Study 8560532 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 123
Study 2128475 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (AF) 6 mg/day
Number of subjects: 121
Study 2128475 — intervention group
Group type: COMPARATOR
Intervention: Gold sodium thiomalate (GST) 50 mg/week
Number of subjects: 121
Study 2128475 — intervention group
Group type: COMPARATOR
Intervention: Gold sodium thiomalate (GST) 50 mg/month after dose reduction
Number of subjects: 121
Study 2128475 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (AF) 4 mg/day after dose reduction
Number of subjects: 121
Study 2128475 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal rate due to adverse events
Number of subjects: 121
Study 373665 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline added to perphenazine
Number of subjects: 35
Study 373665 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine alone
Number of subjects: 35
Study 31157366 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of PEEP (12 cm H2O with alveolar recruitment maneuvers)
Number of subjects: 2013
Study 31157366 — intervention group
Group type: COMPARATOR
Intervention: Low level of PEEP (4 cm H2O)
Number of subjects: 2013
Study 28345162 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide (10 µg initially increased weekly by 5 up to 20 µg)
Number of subjects: 136
Study 28345162 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin (50 mg once daily)
Number of subjects: 136
Study 28345162 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 136
Study 28345162 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 136
Study 26087566 — intervention group
Group type: EXPERIMENTAL
Intervention: Sophora gel (one piece every night for 14 days) and Fluconazole capsules (150 mg, once every three days, four times in total)
Number of subjects: 85
Study 26087566 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole capsules (control group)
Number of subjects: 85
Study 26087566 — intervention group
Group type: EXPERIMENTAL
Intervention: Sophora gel combined with Fluconazole capsules
Number of subjects: 85
Study 22837542 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enhanced speech and language therapy after stroke
Number of subjects: 22
Study 22837542 — intervention group
Group type: COMPARATOR
Intervention: Employed visitor support
Number of subjects: 22
Study 21860188 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (3 mg/kg in 100 ml normal saline)
Number of subjects: 56
Study 21860188 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 56
Study 19699256 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-hydrated condition (H)
Number of subjects: 3
Study 19699256 — intervention group
Group type: COMPARATOR
Intervention: Dry-dehydrated specimens (DH5s and DH10s)
Number of subjects: 3
Study 17485450 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 63
Study 17485450 — intervention group
Group type: COMPARATOR
Intervention: Morphine, atropine, and suxamethonium
Number of subjects: 63
Study 14583740 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 50
Study 14583740 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 50
Study 14583740 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 50
Study 11570048 — intervention group
Group type: EXPERIMENTAL
Intervention: Good health
Number of subjects: 996
Study 11570048 — intervention group
Group type: EXPERIMENTAL
Intervention: Social security and pension
Number of subjects: 996
Study 11570048 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care independence
Number of subjects: 996
Study 11570048 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital satisfaction
Number of subjects: 996
Study 11570048 — intervention group
Group type: EXPERIMENTAL
Intervention: Good relationship with relatives
Number of subjects: 996
Study 9593137 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of RMP plus 400 mg of OFLO and 100 mg of MINO
Number of subjects: 20
Study 9593137 — intervention group
Group type: COMPARATOR
Intervention: 400 mg of OFLO plus 100 mg of MINO
Number of subjects: 20
Study 7923315 — intervention group
Group type: EXPERIMENTAL
Intervention: Clebopride (0.5 mg) and simethicone (200 mg)
Number of subjects: 50
Study 7923315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 3380312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dantrolene sodium (25 mg, twice a day for seven days)
Number of subjects: 40
Study 3380312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30054777 — intervention group
Group type: EXPERIMENTAL
Intervention: event-specific, text message Personalized Drinking Feedback Intervention (TXT PFI)
Number of subjects: 130
Study 30054777 — intervention group
Group type: COMPARATOR
Intervention: control condition
Number of subjects: 130
Study 28774394 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 1358
Study 28774394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1358
Study 26123388 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral feet Cold Pressor Test (CPT)
Number of subjects: 24
Study 26123388 — intervention group
Group type: COMPARATOR
Intervention: Classic Cold Pressor Test (CPT)
Number of subjects: 24
Study 23804517 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (gastric bypass or sleeve gastrectomy)
Number of subjects: 14
Study 23804517 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 14
Study 23804517 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (gastric bypass)
Number of subjects: 14
Study 21697532 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA85A with EPI vaccines
Number of subjects: 214
Study 21697532 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA85A alone
Number of subjects: 214
Study 21697532 — intervention group
Group type: COMPARATOR
Intervention: EPI vaccines alone
Number of subjects: 214
Study 19383885 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of recreational physical activity duration
Number of subjects: 735
Study 19383885 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of physical activity
Number of subjects: 735
Study 19383885 — intervention group
Group type: COMPARATOR
Intervention: High triglycerides (> or =136 mg/dL)
Number of subjects: 735
Study 16942935 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 58
Study 16942935 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 58
Study 15246205 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal protein diet
Number of subjects: 30
Study 15246205 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet
Number of subjects: 30
Study 11348910 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 256
Study 11348910 — intervention group
Group type: COMPARATOR
Intervention: Sustained release oral morphine
Number of subjects: 256
Study 9205818 — intervention group
Group type: EXPERIMENTAL
Intervention: MP suleptanate
Number of subjects: 90
Study 9205818 — intervention group
Group type: COMPARATOR
Intervention: MP succinate
Number of subjects: 90
Study 8489572 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg fluconazole suppository
Number of subjects: 0
Study 8489572 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg fluconazole suppository
Number of subjects: 0
Study 8489572 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg and 25 mg fluconazole suppositories
Number of subjects: 0
Study 3327370 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam (CLN) and Haloperidol (HL)
Number of subjects: 24
Study 3327370 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (HL) and Placebo
Number of subjects: 24
Study 28961427 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (550 mg) and codeine phosphate (30 mg)
Number of subjects: 90
Study 28961427 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac potassium (50 mg)
Number of subjects: 90
Study 28961427 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine hydrochloride (50 mg)
Number of subjects: 90
Study 27697874 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-case cochlear implantation
Number of subjects: 30
Study 27697874 — intervention group
Group type: COMPARATOR
Intervention: Inpatient cochlear implantation
Number of subjects: 30
Study 25118967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid HIV testing without brief risk reduction counseling
Number of subjects: 7
Study 25118967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid HIV testing with brief risk reduction counseling
Number of subjects: 7
Study 25118967 — intervention group
Group type: COMPARATOR
Intervention: Implementation of universal rapid HIV testing without counseling
Number of subjects: 7
Study 25118967 — intervention group
Group type: COMPARATOR
Intervention: Implementation of universal rapid HIV testing with counseling
Number of subjects: 7
Study 25118967 — intervention group
Group type: COMPARATOR
Intervention: Median start-up costs per clinic without counseling
Number of subjects: 7
Study 25118967 — intervention group
Group type: COMPARATOR
Intervention: Median start-up costs per clinic with counseling
Number of subjects: 7
Study 22581341 — intervention group
Group type: EXPERIMENTAL
Intervention: Hood colonoscopy
Number of subjects: 378
Study 22581341 — intervention group
Group type: COMPARATOR
Intervention: Standard examination
Number of subjects: 378
Study 19536877 — intervention group
Group type: EXPERIMENTAL
Intervention: AVPD
Number of subjects: 134
Study 19536877 — intervention group
Group type: EXPERIMENTAL
Intervention: Other PD
Number of subjects: 134
Study 19536877 — intervention group
Group type: EXPERIMENTAL
Intervention: No PD
Number of subjects: 134
Study 19536877 — intervention group
Group type: EXPERIMENTAL
Intervention: Any lifetime mood disorder
Number of subjects: 134
Study 18399022 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 38
Study 18399022 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 38
Study 15805455 — intervention group
Group type: EXPERIMENTAL
Intervention: Active strategy (multifaceted programme including education, discussion, role playing, feedback, and reminders)
Number of subjects: 113
Study 15805455 — intervention group
Group type: COMPARATOR
Intervention: Standard dissemination (control group receiving guidelines by mail)
Number of subjects: 113
Study 12584785 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu'an Liquid (FAL) for retention enema
Number of subjects: 89
Study 12584785 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy of western medicine
Number of subjects: 89
Study 11188494 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretest-posttest analyses
Number of subjects: 0
Study 11188494 — intervention group
Group type: COMPARATOR
Intervention: Cross-sectional analyses
Number of subjects: 0
Study 9174473 — intervention group
Group type: EXPERIMENTAL
Intervention: High-amylose starch diet
Number of subjects: 24
Study 1283192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine (16 mg q.d.)
Number of subjects: 125
Study 1283192 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide/Triamterene (HCT/T) (25/50 mg q.d.)
Number of subjects: 125
Study 1283192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine (1 x 8 mg)
Number of subjects: 125
Study 1283192 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (1 x 10 mg)
Number of subjects: 125
Study 3574642 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 M sodium lactate (5 ml/kg in 5% dextrose/water) over a 20‐min period
Number of subjects: 27
Study 3574642 — intervention group
Group type: COMPARATOR
Intervention: 5% dextrose in water
Number of subjects: 27
Study 30372582 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation with enalapril
Number of subjects: 2529
Study 30372582 — intervention group
Group type: COMPARATOR
Intervention: Enalapril alone
Number of subjects: 2529
Study 26823970 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic advice, manual soft tissue treatment and exercises
Number of subjects: 237
Study 26823970 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic advice, manual soft tissue treatment and exercises plus manipulative therapy
Number of subjects: 237
Study 24290858 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-reconstruction group (Group A, n=20)
Number of subjects: 40
Study 24290858 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B, n=20)
Number of subjects: 40
Study 22662733 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual in-person psychotherapy
Number of subjects: 0
Study 22662733 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy via video teleconferencing
Number of subjects: 0
Study 20422879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyosine N-butyl bromide
Number of subjects: 116
Study 20422879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 19045976 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based behavior therapy
Number of subjects: 31
Study 19045976 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (control)
Number of subjects: 31
Study 15643534 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 2
Study 15643534 — intervention group
Group type: COMPARATOR
Intervention: Concentric training
Number of subjects: 2
Study 14562015 — intervention group
Group type: EXPERIMENTAL
Intervention: Written feedback plus course
Number of subjects: 160
Study 14562015 — intervention group
Group type: EXPERIMENTAL
Intervention: Course alone
Number of subjects: 160
Study 14562015 — intervention group
Group type: EXPERIMENTAL
Intervention: Written feedback alone
Number of subjects: 160
Study 14562015 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 160
Study 10652394 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil/propofol anesthetic
Number of subjects: 80
Study 10652394 — intervention group
Group type: COMPARATOR
Intervention: Propofol/fentanyl combination
Number of subjects: 80
Study 9050095 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressurized aerosol of ipratropium bromide (80 mg single dose)
Number of subjects: 20
Study 9050095 — intervention group
Group type: COMPARATOR
Intervention: Aqueous pump spray of ipratropium bromide (80 mg single dose)
Number of subjects: 20
Study 30701365 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive liver resection (LLR)
Number of subjects: 193
Study 30701365 — intervention group
Group type: COMPARATOR
Intervention: Open liver resection (OLR)
Number of subjects: 193
Study 29122196 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration applied to the low back (3‐min duration) at the 2‐h and 2.25‐h marks
Number of subjects: 18
Study 29122196 — intervention group
Group type: COMPARATOR
Intervention: No vibration (control condition)
Number of subjects: 18
Study 27373347 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) frozen section (FS) before Z0011
Number of subjects: 250
Study 27373347 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) frozen section (FS) after Z0011
Number of subjects: 250
Study 27373347 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND) post-Z0011
Number of subjects: 250
Study 27373347 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node positivity
Number of subjects: 250